RIBAVIRIN

RIBAVIRIN was reported 63953 times

RIBAVIRIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANAL PRURITUS 819 0.3943
1 VOGT-KOYANAGI-HARADA SYNDROME 38 0.3393
2 HEPATITIS C RNA POSITIVE 58 0.3392
3 ANORECTAL DISCOMFORT 1651 0.3103
4 HEPATITIS C RNA INCREASED 103 0.3012
5 HEPATIC HYDROTHORAX 21 0.2658
6 AMAUROSIS FUGAX 231 0.2145
7 VIRAL LOAD DECREASED 28 0.1918
8 HEPATITIS C 2236 0.1850
9 GENOTYPE DRUG RESISTANCE TEST POSITIVE 180 0.1751
10 PORPHYRIA NON-ACUTE 68 0.1563
11 REMISSION NOT ACHIEVED 96 0.1543
12 VIRAL LOAD 25 0.1445
13 HEPATIC CANCER RECURRENT 41 0.1444
14 CHRONIC HEPATITIS C 55 0.1392
15 HEPATOCELLULAR CARCINOMA 967 0.1270
16 HEPATITIS E 192 0.1215
17 PAINFUL DEFAECATION 80 0.1149
18 CRYOGLOBULINAEMIA 76 0.1063
19 RETINAL EXUDATES 98 0.1047
20 ANTI-ERYTHROPOIETIN ANTIBODY POSITIVE 25 0.0996
21 VIRAL LOAD INCREASED 381 0.0980
22 BLEEDING VARICOSE VEIN 45 0.0832
23 HEPATITIS C VIRUS TEST POSITIVE 48 0.0816
24 PROCTALGIA 503 0.0782
25 CUTANEOUS SARCOIDOSIS 32 0.0742
26 OESOPHAGEAL VARICES HAEMORRHAGE 158 0.0727
27 ANORECTAL DISORDER 124 0.0621
28 RETINOPATHY 218 0.0584
29 HEPATIC ENCEPHALOPATHY 507 0.0543
30 VARICES OESOPHAGEAL 159 0.0525
31 HAEMORRHOIDS 986 0.0505
32 BASEDOW'S DISEASE 23 0.0489
33 HEPATORENAL SYNDROME 82 0.0485
34 EXPOSURE VIA DIRECT CONTACT 46 0.0484
35 HYPERURICAEMIA 198 0.0481
36 LIVER TRANSPLANT REJECTION 86 0.0478
37 LIVER TRANSPLANT 174 0.0478
38 HYPERBILIRUBINAEMIA 489 0.0472
39 URINARY TRACT DISORDER 209 0.0464
40 GLOMERULONEPHRITIS MEMBRANOPROLIFERATIVE 24 0.0458
41 VIROLOGIC FAILURE 237 0.0440
42 HEPATIC CIRRHOSIS 826 0.0439
43 ANAEMIA 8370 0.0438
44 BILIRUBIN CONJUGATED INCREASED 102 0.0436
45 ASCITES 1181 0.0401
46 HEPATITIS B REACTIVATION 126 0.0397
47 HEPATIC NEOPLASM MALIGNANT 84 0.0396
48 PREGNANCY OF PARTNER 28 0.0395
49 HAEMOLYTIC ANAEMIA 342 0.0381
50 RED BLOOD CELL COUNT DECREASED 1055 0.0369
51 BLOOD BILIRUBIN UNCONJUGATED INCREASED 25 0.0344
52 HAEMORRHAGIC STROKE 268 0.0343
53 MITOCHONDRIAL TOXICITY 28 0.0341
54 ALPHA 1 FOETOPROTEIN INCREASED 24 0.0337
55 RASH GENERALISED 855 0.0330
56 ANAL HAEMORRHAGE 92 0.0328
57 HEPATIC FAILURE 980 0.0325
58 HEPATIC PAIN 137 0.0321
59 BLOOD BILIRUBIN INCREASED 866 0.0320
60 WHITE BLOOD CELL COUNT DECREASED 3443 0.0317
61 HAEMORRHOIDAL HAEMORRHAGE 152 0.0311
62 PORTAL VEIN THROMBOSIS 95 0.0294
63 ANTICOAGULATION DRUG LEVEL BELOW THERAPEUTIC 22 0.0285
64 INFLUENZA LIKE ILLNESS 2305 0.0280
65 VIRAL MUTATION IDENTIFIED 103 0.0279
66 ALANINE AMINOTRANSFERASE DECREASED 20 0.0276
67 PORTAL HYPERTENSION 84 0.0272
68 CHRONIC HEPATITIS 22 0.0272
69 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 87 0.0268
70 AMMONIA INCREASED 135 0.0264
71 HEPATIC FIBROSIS 90 0.0262
72 HAEMOGLOBIN DECREASED 2628 0.0256
73 PRURITUS GENERALISED 547 0.0253
74 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 40 0.0250
75 NO THERAPEUTIC RESPONSE 296 0.0243
76 PLATELET COUNT DECREASED 2565 0.0240
77 BLOOD URIC ACID INCREASED 138 0.0239
78 RASH PRURITIC 1247 0.0230
79 GENERALISED OEDEMA 279 0.0225
80 OCULAR DISCOMFORT 250 0.0222
81 JAUNDICE 599 0.0222
82 FACIAL PALSY 48 0.0222
83 NEUTROPHIL COUNT DECREASED 899 0.0220
84 BLOOD COUNT ABNORMAL 315 0.0208
85 BLOOD BILIRUBIN ABNORMAL 26 0.0203
86 APLASIA PURE RED CELL 69 0.0200
87 APHTHOUS STOMATITIS 46 0.0199
88 VIRAEMIA 27 0.0195
89 EXPOSURE VIA FATHER 25 0.0192
90 OCULAR ICTERUS 83 0.0191
91 ORAL INTAKE REDUCED 46 0.0190
92 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 47 0.0190
93 IRRITABILITY 1128 0.0187
94 HAEMOLYSIS 144 0.0186
95 DYSGEUSIA 1382 0.0186
96 HAEMATEMESIS 458 0.0180
97 HOMICIDAL IDEATION 73 0.0180
98 FAECES PALE 40 0.0180
99 VIITH NERVE PARALYSIS 62 0.0179
100 HEPATIC NEOPLASM 58 0.0178
101 BLOOD IRON INCREASED 33 0.0176
102 APLASTIC ANAEMIA 91 0.0174
103 CHILLS 2019 0.0172
104 PHOTOPHOBIA 322 0.0171
105 LEUKOPENIA 852 0.0170
106 RASH PAPULAR 371 0.0165
107 INTERVERTEBRAL DISCITIS 31 0.0164
108 RETINAL HAEMORRHAGE 116 0.0163
109 PERITONITIS BACTERIAL 164 0.0162
110 SARCOIDOSIS 75 0.0158
111 ACUTE PSYCHOSIS 39 0.0158
112 APHAGIA 74 0.0154
113 TRANSFUSION 158 0.0151
114 NASAL ULCER 24 0.0150
115 FIBROSIS 46 0.0149
116 MOOD SWINGS 473 0.0148
117 HEAD DISCOMFORT 262 0.0148
118 PANCYTOPENIA 815 0.0146
119 HEPATIC MASS 28 0.0145
120 YELLOW SKIN 68 0.0145
121 TONGUE ULCERATION 49 0.0145
122 RED BLOOD CELL COUNT ABNORMAL 21 0.0143
123 DECREASED APPETITE 3275 0.0141
124 AUTOIMMUNE THYROIDITIS 52 0.0137
125 FEELING OF BODY TEMPERATURE CHANGE 79 0.0135
126 RASH VESICULAR 65 0.0134
127 HAEMATOCRIT DECREASED 262 0.0132
128 CHAPPED LIPS 57 0.0131
129 SOFT TISSUE INFECTION 24 0.0131
130 BLOOD DISORDER 105 0.0131
131 AUTOIMMUNE HEPATITIS 91 0.0131
132 HEPATITIS CHOLESTATIC 78 0.0129
133 LICHEN PLANUS 30 0.0129
134 INSOMNIA 3439 0.0129
135 PAROSMIA 97 0.0128
136 TRANSPLANT FAILURE 31 0.0126
137 PRESYNCOPE 302 0.0124
138 RASH 5358 0.0123
139 FATIGUE 9564 0.0123
140 ALTERED STATE OF CONSCIOUSNESS 265 0.0122
141 MILIARIA 21 0.0122
142 LIP BLISTER 33 0.0121
143 PRURITUS 4647 0.0121
144 CHEILITIS 65 0.0120
145 THROMBOCYTOPENIA 1335 0.0119
146 ANGER 403 0.0119
147 ENCEPHALOPATHY 291 0.0118
148 TREATMENT FAILURE 969 0.0117
149 ORAL CANDIDIASIS 153 0.0116
150 SERUM FERRITIN INCREASED 61 0.0116
151 CHROMATURIA 261 0.0116
152 TRANSPLANT REJECTION 92 0.0115
153 DEPRESSION 2575 0.0113
154 PYELONEPHRITIS ACUTE 22 0.0112
155 TONGUE DISCOLOURATION 49 0.0112
156 DEPRESSIVE SYMPTOM 39 0.0111
157 GLOMERULONEPHRITIS 27 0.0110
158 IMMUNE THROMBOCYTOPENIC PURPURA 31 0.0110
159 DEAFNESS NEUROSENSORY 36 0.0109
160 ERYTHEMA MULTIFORME 102 0.0109
161 ALANINE AMINOTRANSFERASE ABNORMAL 23 0.0109
162 OPTIC NEUROPATHY 23 0.0109
163 ANAEMIA MACROCYTIC 23 0.0108
164 THYROIDITIS 32 0.0106
165 RECTAL HAEMORRHAGE 448 0.0104
166 PYREXIA 3583 0.0103
167 PULMONARY TUBERCULOSIS 44 0.0103
168 PHOTOSENSITIVITY REACTION 170 0.0103
169 ANOREXIA 132 0.0102
170 THYROID FUNCTION TEST ABNORMAL 42 0.0101
171 BLOOD ALBUMIN DECREASED 80 0.0101
172 SPLENOMEGALY 118 0.0101
173 PLATELET DISORDER 25 0.0099
174 STAPHYLOCOCCAL BACTERAEMIA 43 0.0099
175 LOCAL SWELLING 172 0.0099
176 DIPLOPIA 255 0.0098
177 CD4 LYMPHOCYTES DECREASED 21 0.0098
178 THIRST 174 0.0097
179 CANDIDIASIS 39 0.0097
180 ALCOHOL ABUSE 26 0.0097
181 BLOOD POTASSIUM DECREASED 291 0.0097
182 ASTHENIA 3618 0.0096
183 DRY MOUTH 779 0.0096
184 INJECTION SITE RASH 291 0.0095
185 TOXIC SKIN ERUPTION 95 0.0094
186 MULTI-ORGAN FAILURE 163 0.0094
187 NAUSEA 7440 0.0094
188 NEUTROPENIA 1275 0.0094
189 WHITE BLOOD CELL DISORDER 25 0.0093
190 THYROID DISORDER 144 0.0093
191 FACIAL PARESIS 33 0.0093
192 HYPERTHYROIDISM 135 0.0093
193 BILIARY COLIC 27 0.0093
194 WEIGHT DECREASED 2589 0.0093
195 ORAL PAIN 204 0.0091
196 TEARFULNESS 39 0.0091
197 EXCORIATION 23 0.0091
198 OPTIC ISCHAEMIC NEUROPATHY 35 0.0090
199 FAECES DISCOLOURED 196 0.0090
200 BREATH ODOUR 22 0.0090
201 GINGIVAL BLEEDING 121 0.0089
202 ERYTHEMA NODOSUM 31 0.0088
203 DRUG ERUPTION 156 0.0088
204 THERAPEUTIC PRODUCT INEFFECTIVE 34 0.0088
205 AFFECT LABILITY 83 0.0086
206 HEPATIC LESION 37 0.0085
207 RASH ERYTHEMATOUS 408 0.0085
208 STAPHYLOCOCCAL SEPSIS 42 0.0085
209 TINNITUS 390 0.0085
210 LETHARGY 486 0.0084
211 TONGUE DISORDER 61 0.0084
212 GINGIVAL PAIN 67 0.0084
213 DEHYDRATION 1121 0.0084
214 ORAL FUNGAL INFECTION 23 0.0084
215 ALCOHOL USE 31 0.0084
216 HYPERSENSITIVITY VASCULITIS 22 0.0084
217 MOUTH ULCERATION 175 0.0083
218 SKIN DISORDER 275 0.0082
219 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 212 0.0082
220 HAEMATURIA 282 0.0082
221 PROSTATITIS 25 0.0082
222 ENDOCARDITIS 42 0.0082
223 DISTURBANCE IN ATTENTION 441 0.0082
224 BRONCHOPNEUMONIA 28 0.0082
225 ALCOHOLISM 35 0.0082
226 ALANINE AMINOTRANSFERASE INCREASED 501 0.0082
227 HERPES VIRUS INFECTION 47 0.0082
228 FEELING COLD 227 0.0081
229 DRY SKIN 1088 0.0081
230 VOMITING 3810 0.0081
231 MYALGIA 1374 0.0081
232 FORMICATION 56 0.0080
233 STOMATITIS 487 0.0080
234 EPISTAXIS 600 0.0080
235 APPETITE DISORDER 53 0.0080
236 NORMOCHROMIC NORMOCYTIC ANAEMIA 24 0.0080
237 INCREASED UPPER AIRWAY SECRETION 41 0.0080
238 DECREASED INTEREST 47 0.0080
239 FURUNCLE 63 0.0079
240 CHOLECYSTITIS ACUTE 45 0.0079
241 ESCHERICHIA SEPSIS 23 0.0079
242 DYSPNOEA EXERTIONAL 298 0.0079
243 GLOSSITIS 28 0.0079
244 NEPHROTIC SYNDROME 54 0.0079
245 SLUGGISHNESS 80 0.0078
246 SYNCOPE 784 0.0078
247 PROCEDURAL COMPLICATION 60 0.0078
248 NASAL DRYNESS 49 0.0078
249 EYE PAIN 439 0.0078
250 CHOLANGITIS 48 0.0077
251 RETINAL VEIN OCCLUSION 22 0.0076
252 HEADACHE 4795 0.0076
253 SKIN ODOUR ABNORMAL 30 0.0076
254 HEPATIC CANCER 182 0.0076
255 HYPERAESTHESIA 62 0.0075
256 FULL BLOOD COUNT DECREASED 152 0.0075
257 BLINDNESS 306 0.0075
258 DEPRESSED MOOD 396 0.0075
259 TYPE 1 DIABETES MELLITUS 45 0.0075
260 RENAL IMPAIRMENT 622 0.0074
261 DRY THROAT 75 0.0074
262 ALOPECIA 1444 0.0073
263 PARANOIA 126 0.0073
264 SUBCUTANEOUS ABSCESS 35 0.0073
265 MOOD ALTERED 199 0.0073
266 PLEURISY 43 0.0072
267 SKIN REACTION 102 0.0072
268 SINUS HEADACHE 43 0.0072
269 INTERNATIONAL NORMALISED RATIO DECREASED 29 0.0072
270 CRYING 260 0.0071
271 SKIN ULCER 184 0.0071
272 POLYDIPSIA 28 0.0071
273 ASPARTATE AMINOTRANSFERASE INCREASED 373 0.0070
274 ORAL HERPES 137 0.0070
275 EMOTIONAL DISORDER 216 0.0070
276 INJECTION SITE INFECTION 23 0.0070
277 ERYSIPELAS 35 0.0070
278 HAEMATOTOXICITY 66 0.0069
279 ANAL FISSURE 37 0.0069
280 SEPSIS 768 0.0069
281 GLOSSODYNIA 154 0.0069
282 HAEMOGLOBIN ABNORMAL 44 0.0068
283 TRANSAMINASES INCREASED 152 0.0068
284 FACE OEDEMA 115 0.0068
285 BODY TEMPERATURE INCREASED 139 0.0068
286 PATHOGEN RESISTANCE 62 0.0068
287 FLUID INTAKE REDUCED 34 0.0068
288 CARDIO-RESPIRATORY ARREST 283 0.0068
289 BLISTER 380 0.0068
290 RETINAL DETACHMENT 62 0.0067
291 RENAL FAILURE ACUTE 286 0.0067
292 DIARRHOEA HAEMORRHAGIC 63 0.0067
293 MOUTH HAEMORRHAGE 49 0.0067
294 COMA 318 0.0067
295 MENTAL DISORDER 290 0.0067
296 HYPERSOMNIA 191 0.0067
297 PANCREATITIS ACUTE 148 0.0066
298 DIZZINESS POSTURAL 63 0.0065
299 B-CELL LYMPHOMA 22 0.0065
300 PSYCHOTIC DISORDER 190 0.0064
301 OEDEMA MOUTH 21 0.0064
302 APPENDICITIS 60 0.0064
303 BLOOD THYROID STIMULATING HORMONE DECREASED 29 0.0064
304 VISION BLURRED 875 0.0064
305 PSYCHIATRIC SYMPTOM 47 0.0064
306 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 21 0.0064
307 PYELONEPHRITIS 55 0.0063
308 BONE MARROW FAILURE 128 0.0063
309 HYPOTHYROIDISM 201 0.0063
310 WHITE BLOOD CELL COUNT ABNORMAL 40 0.0063
311 RASH MACULO-PAPULAR 139 0.0062
312 GINGIVAL DISORDER 24 0.0062
313 RASH MACULAR 218 0.0062
314 BK VIRUS INFECTION 21 0.0062
315 SELF-INJURIOUS IDEATION 26 0.0062
316 PROTHROMBIN TIME PROLONGED 37 0.0062
317 VASCULITIS 72 0.0062
318 INCOHERENT 40 0.0062
319 HYPOALBUMINAEMIA 48 0.0062
320 MASS 86 0.0061
321 FRUSTRATION 22 0.0061
322 MENINGITIS 41 0.0061
323 PALLOR 167 0.0061
324 HEPATOMEGALY 60 0.0061
325 GASTROENTERITIS 89 0.0061
326 BLOOD CREATININE INCREASED 395 0.0060
327 GUILLAIN-BARRE SYNDROME 29 0.0060
328 PAPILLOEDEMA 27 0.0060
329 BLOOD THYROID STIMULATING HORMONE INCREASED 55 0.0060
330 HEPATITIS B 36 0.0060
331 AMYLASE INCREASED 22 0.0060
332 LIVER DISORDER 264 0.0059
333 LYMPHOPENIA 84 0.0059
334 VULVOVAGINAL PRURITUS 30 0.0059
335 HYPOPHAGIA 151 0.0059
336 DYSPNOEA 3339 0.0059
337 FLANK PAIN 55 0.0059
338 ACUTE HEPATIC FAILURE 80 0.0058
339 RENAL PAIN 62 0.0058
340 PROTEIN TOTAL DECREASED 22 0.0058
341 LIP DRY 53 0.0058
342 PHARYNGOLARYNGEAL PAIN 31 0.0058
343 CHOLELITHIASIS 191 0.0058
344 DIARRHOEA 3751 0.0058
345 HYPOVOLAEMIA 34 0.0058
346 DEAFNESS UNILATERAL 32 0.0058
347 BLOOD UREA INCREASED 97 0.0058
348 DRUG DOSE OMISSION 956 0.0058
349 HORDEOLUM 25 0.0058
350 DERMATITIS 121 0.0058
351 RETCHING 123 0.0058
352 DIZZINESS 2877 0.0058
353 CREATININE RENAL CLEARANCE DECREASED 23 0.0057
354 LIPASE INCREASED 44 0.0057
355 LACERATION 54 0.0057
356 DYSPEPSIA 558 0.0057
357 HAEMATOCHEZIA 313 0.0057
358 EAR PAIN 110 0.0057
359 CACHEXIA 29 0.0056
360 GENERALISED ERYTHEMA 32 0.0056
361 BLOOD SODIUM DECREASED 106 0.0056
362 BLOOD TEST ABNORMAL 79 0.0056
363 UPPER GASTROINTESTINAL HAEMORRHAGE 94 0.0056
364 POOR QUALITY SLEEP 120 0.0056
365 IMMUNE SYSTEM DISORDER 73 0.0055
366 BONE PAIN 323 0.0055
367 BLOOD IRON DECREASED 65 0.0055
368 DYSURIA 201 0.0055
369 ORAL DISORDER 40 0.0055
370 SENSATION OF HEAVINESS 21 0.0054
371 FAECAL INCONTINENCE 26 0.0054
372 ABSCESS LIMB 23 0.0054
373 STAPHYLOCOCCAL INFECTION 178 0.0054
374 ABDOMINAL PAIN 1254 0.0054
375 COUGH 1511 0.0054
376 PERSONALITY CHANGE 50 0.0054
377 DRUG INTERACTION 852 0.0054
378 MUSCLE ATROPHY 68 0.0054
379 SUNBURN 40 0.0054
380 AFFECTIVE DISORDER 42 0.0053
381 SEPTIC SHOCK 232 0.0053
382 SUICIDAL IDEATION 488 0.0053
383 HAEMOPTYSIS 148 0.0053
384 TOOTH ABSCESS 54 0.0053
385 GRANULOCYTOPENIA 30 0.0053
386 TOOTHACHE 95 0.0052
387 OEDEMA PERIPHERAL 635 0.0052
388 FUNGAL SKIN INFECTION 21 0.0052
389 DERMATITIS EXFOLIATIVE 26 0.0052
390 GINGIVITIS 28 0.0052
391 PANIC ATTACK 189 0.0052
392 FEELING OF DESPAIR 24 0.0051
393 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 26 0.0051
394 OROPHARYNGEAL PAIN 475 0.0051
395 ABDOMINAL PAIN UPPER 1044 0.0051
396 PANCREATITIS 268 0.0051
397 BACTERAEMIA 60 0.0051
398 ANAL ABSCESS 27 0.0050
399 LYMPHADENOPATHY 177 0.0050
400 SKIN LESION 137 0.0050
401 IRON DEFICIENCY ANAEMIA 46 0.0050
402 RENAL FUNCTION TEST ABNORMAL 23 0.0049
403 CHOLECYSTITIS 59 0.0049
404 SKIN MASS 33 0.0049
405 PHARYNGITIS 61 0.0049
406 MALNUTRITION 55 0.0049
407 CANDIDA INFECTION 83 0.0049
408 ABDOMINAL DISTENSION 513 0.0049
409 GASTROINTESTINAL INFECTION 44 0.0049
410 INCREASED TENDENCY TO BRUISE 45 0.0049
411 POLYURIA 40 0.0049
412 GLOMERULAR FILTRATION RATE DECREASED 60 0.0049
413 CONFUSIONAL STATE 789 0.0049
414 VISUAL DISTURBANCE 28 0.0049
415 AMNESIA 316 0.0049
416 GOUT 87 0.0048
417 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 342 0.0048
418 MANIA 79 0.0048
419 COLITIS ISCHAEMIC 32 0.0047
420 ESCHERICHIA INFECTION 39 0.0047
421 MEMORY IMPAIRMENT 651 0.0047
422 GASTRITIS 124 0.0047
423 POLLAKIURIA 196 0.0047
424 RENAL FAILURE 622 0.0047
425 ANXIETY 1331 0.0047
426 SWELLING FACE 304 0.0047
427 DISORIENTATION 185 0.0047
428 CHEST PAIN 864 0.0047
429 TACHYCARDIA 414 0.0047
430 EMPHYSEMA 47 0.0047
431 ABASIA 115 0.0046
432 MAJOR DEPRESSION 34 0.0046
433 VARICOSE VEIN 24 0.0046
434 MALAISE 2036 0.0046
435 ACUTE RESPIRATORY DISTRESS SYNDROME 82 0.0046
436 LUNG INFECTION 72 0.0046
437 ABDOMINAL TENDERNESS 23 0.0046
438 HEPATIC FUNCTION ABNORMAL 172 0.0046
439 CELLULITIS 232 0.0046
440 HYPERCHLORHYDRIA 27 0.0046
441 ENERGY INCREASED 27 0.0046
442 VIRAL INFECTION 152 0.0046
443 THINKING ABNORMAL 85 0.0046
444 DYSPHEMIA 20 0.0046
445 FOOD CRAVING 24 0.0046
446 ASTHENOPIA 25 0.0045
447 SKIN INFECTION 51 0.0045
448 STEVENS-JOHNSON SYNDROME 101 0.0045
449 LOCALISED OEDEMA 21 0.0045
450 MENTAL IMPAIRMENT 110 0.0045
451 RASH PUSTULAR 33 0.0045
452 ODYNOPHAGIA 27 0.0045
453 INJECTION SITE REACTION 310 0.0045
454 PANCREATIC DISORDER 22 0.0045
455 PHOTOPSIA 28 0.0044
456 VISUAL ACUITY REDUCED 147 0.0044
457 PURPURA 39 0.0044
458 MELAENA 97 0.0044
459 AGGRESSION 220 0.0044
460 VITREOUS FLOATERS 43 0.0044
461 EATING DISORDER 93 0.0044
462 NIGHT SWEATS 140 0.0043
463 BACTERIAL INFECTION 81 0.0043
464 ORAL DISCOMFORT 60 0.0043
465 VERTIGO 263 0.0043
466 DRUG RESISTANCE 110 0.0043
467 HYPOGAMMAGLOBULINAEMIA 28 0.0043
468 MENTAL STATUS CHANGES 118 0.0042
469 OEDEMA 230 0.0042
470 UROSEPSIS 39 0.0042
471 APATHY 61 0.0042
472 CONVULSION 239 0.0042
473 LOSS OF CONSCIOUSNESS 533 0.0042
474 INJECTION SITE ERYTHEMA 516 0.0042
475 SUBARACHNOID HAEMORRHAGE 42 0.0041
476 FEELING HOT 251 0.0041
477 BLOOD CALCIUM DECREASED 46 0.0041
478 LABORATORY TEST ABNORMAL 120 0.0041
479 INCORRECT DRUG ADMINISTRATION DURATION 114 0.0040
480 HYPERHIDROSIS 520 0.0040
481 IMPAIRED WORK ABILITY 86 0.0040
482 LYMPHOMA 62 0.0040
483 MUSCULOSKELETAL PAIN 210 0.0040
484 PREGNANCY 80 0.0040
485 SLEEP DISORDER 281 0.0040
486 PAPULE 28 0.0040
487 RENAL DISORDER 185 0.0040
488 DRUG ADMINISTRATION ERROR 121 0.0039
489 BLOOD GLUCOSE FLUCTUATION 43 0.0039
490 BLOOD TRIGLYCERIDES INCREASED 69 0.0039
491 RESPIRATORY SYNCYTIAL VIRUS INFECTION 34 0.0039
492 FEELING ABNORMAL 934 0.0039
493 HAIR TEXTURE ABNORMAL 52 0.0039
494 NERVOUSNESS 203 0.0039
495 BRONCHOPULMONARY ASPERGILLOSIS 30 0.0039
496 HYPERTENSIVE CRISIS 43 0.0039
497 SENSORY DISTURBANCE 62 0.0039
498 FREQUENT BOWEL MOVEMENTS 104 0.0038
499 GAMMA-GLUTAMYLTRANSFERASE INCREASED 85 0.0038
500 GENERAL PHYSICAL CONDITION ABNORMAL 26 0.0038
501 PRODUCTIVE COUGH 183 0.0038
502 EAR INFECTION 102 0.0038
503 EXERCISE TOLERANCE DECREASED 22 0.0038
504 HYPOKALAEMIA 176 0.0038
505 SOCIAL AVOIDANT BEHAVIOUR 22 0.0038
506 BLOOD URINE PRESENT 72 0.0038
507 ABNORMAL FAECES 31 0.0038
508 SUDDEN DEATH 40 0.0038
509 BACK PAIN 875 0.0038
510 GASTROENTERITIS VIRAL 68 0.0038
511 HYPERTRIGLYCERIDAEMIA 22 0.0038
512 EYE HAEMORRHAGE 50 0.0037
513 VISUAL FIELD DEFECT 27 0.0037
514 ATELECTASIS 36 0.0037
515 PULMONARY CONGESTION 49 0.0037
516 ELECTROLYTE IMBALANCE 43 0.0037
517 DISSEMINATED INTRAVASCULAR COAGULATION 52 0.0037
518 BIPOLAR DISORDER 40 0.0037
519 COAGULOPATHY 61 0.0037
520 URINE OUTPUT DECREASED 32 0.0037
521 SUPRAVENTRICULAR TACHYCARDIA 35 0.0037
522 MATERNAL DRUGS AFFECTING FOETUS 28 0.0036
523 SWOLLEN TONGUE 114 0.0036
524 PERIPHERAL COLDNESS 50 0.0036
525 ARTHRALGIA 1514 0.0036
526 SKIN FISSURES 71 0.0036
527 COLD SWEAT 64 0.0036
528 PAIN 2228 0.0036
529 HYPERVENTILATION 21 0.0036
530 CONCUSSION 28 0.0036
531 AGRANULOCYTOSIS 67 0.0036
532 PALPITATIONS 422 0.0036
533 ANURIA 31 0.0036
534 HALLUCINATION, AUDITORY 57 0.0036
535 AGEUSIA 89 0.0036
536 HYPERGLYCAEMIA 130 0.0036
537 DEAFNESS 93 0.0036
538 MUSCULOSKELETAL CHEST PAIN 55 0.0035
539 AGITATION 259 0.0035
540 DENTAL CARIES 39 0.0035
541 REFUSAL OF TREATMENT BY PATIENT 23 0.0035
542 SCAB 40 0.0035
543 HEPATIC STEATOSIS 65 0.0035
544 DISEASE RECURRENCE 166 0.0035
545 TOOTH EXTRACTION 43 0.0035
546 RESTLESSNESS 126 0.0034
547 CYTOMEGALOVIRUS INFECTION 57 0.0034
548 DYSARTHRIA 129 0.0034
549 BEDRIDDEN 45 0.0034
550 TREMOR 566 0.0034
551 POOR QUALITY DRUG ADMINISTERED 22 0.0034
552 SOMNOLENCE 682 0.0034
553 ABDOMINAL DISCOMFORT 568 0.0034
554 ACTIVITIES OF DAILY LIVING IMPAIRED 67 0.0034
555 ECZEMA 177 0.0034
556 THERMAL BURN 24 0.0034
557 NOCTURIA 41 0.0034
558 MUSCLE SPASMS 618 0.0034
559 CONSTIPATION 734 0.0034
560 GRAND MAL CONVULSION 31 0.0034
561 CYTOPENIA 41 0.0033
562 THERAPY NON-RESPONDER 150 0.0033
563 DERMATITIS BULLOUS 24 0.0033
564 GASTRIC ULCER 63 0.0033
565 MIGRAINE 316 0.0033
566 RESTLESS LEGS SYNDROME 60 0.0033
567 HYPONATRAEMIA 185 0.0033
568 PERICARDITIS 55 0.0033
569 EYELID OEDEMA 38 0.0033
570 DRY EYE 163 0.0033
571 MENORRHAGIA 64 0.0033
572 PETECHIAE 34 0.0033
573 PULMONARY ARTERIAL HYPERTENSION 47 0.0032
574 BRONCHITIS 239 0.0032
575 BLOOD LACTATE DEHYDROGENASE INCREASED 51 0.0032
576 BRADYPHRENIA 21 0.0032
577 EAR DISCOMFORT 33 0.0032
578 GASTROOESOPHAGEAL REFLUX DISEASE 258 0.0032
579 EYE SWELLING 119 0.0032
580 HALLUCINATION 241 0.0032
581 ABSCESS 51 0.0032
582 LACTIC ACIDOSIS 103 0.0032
583 ENCEPHALITIS 22 0.0032
584 SKIN DISCOLOURATION 146 0.0032
585 CONTUSION 305 0.0032
586 FACIAL PARALYSIS 27 0.0032
587 SPUTUM DISCOLOURED 30 0.0032
588 PNEUMONIA 1024 0.0032
589 FAECES SOFT 23 0.0032
590 FACIAL PAIN 28 0.0031
591 BREAST MASS 21 0.0031
592 CARDIAC MURMUR 27 0.0031
593 NEPHROPATHY TOXIC 35 0.0031
594 TOOTH INFECTION 41 0.0031
595 SINUS CONGESTION 42 0.0031
596 TEMPERATURE INTOLERANCE 32 0.0031
597 ERUCTATION 60 0.0031
598 TOOTH FRACTURE 34 0.0031
599 SKIN EXFOLIATION 260 0.0031
600 ABORTION INDUCED 29 0.0031
601 PNEUMONIA BACTERIAL 28 0.0030
602 SCRATCH 32 0.0030
603 DRUG LEVEL INCREASED 50 0.0030
604 CHOLESTASIS 58 0.0030
605 URINARY TRACT INFECTION 515 0.0030
606 TREATMENT NONCOMPLIANCE 165 0.0030
607 HEPATITIS 77 0.0030
608 RESPIRATORY DISORDER 90 0.0030
609 ATRIAL FLUTTER 24 0.0030
610 BLOOD PRESSURE INCREASED 459 0.0030
611 DRUG-INDUCED LIVER INJURY 94 0.0030
612 RESPIRATORY TRACT INFECTION 78 0.0030
613 PHARYNGEAL OEDEMA 46 0.0030
614 BLINDNESS TRANSIENT 22 0.0030
615 CARDIOMYOPATHY 44 0.0030
616 CHOLECYSTECTOMY 34 0.0030
617 MUSCLE TIGHTNESS 48 0.0030
618 LIVER FUNCTION TEST ABNORMAL 86 0.0030
619 PERICARDIAL EFFUSION 68 0.0029
620 HEPATIC ENZYME INCREASED 200 0.0029
621 ABNORMAL DREAMS 81 0.0029
622 HYPOAESTHESIA 439 0.0029
623 MULTIPLE ORGAN DYSFUNCTION SYNDROME 83 0.0029
624 INITIAL INSOMNIA 30 0.0029
625 ECCHYMOSIS 20 0.0029
626 VISUAL IMPAIRMENT 361 0.0029
627 DRUG SCREEN POSITIVE 23 0.0029
628 DELIRIUM 101 0.0029
629 FLATULENCE 165 0.0029
630 ACUTE CORONARY SYNDROME 24 0.0029
631 MYOSITIS 26 0.0029
632 EOSINOPHIL COUNT INCREASED 24 0.0029
633 AUTOIMMUNE DISORDER 28 0.0029
634 BLOOD ALKALINE PHOSPHATASE INCREASED 71 0.0029
635 DIFFUSE LARGE B-CELL LYMPHOMA 22 0.0029
636 ABDOMINAL PAIN LOWER 72 0.0028
637 ATRIOVENTRICULAR BLOCK 22 0.0028
638 INJECTION SITE BRUISING 227 0.0028
639 MUSCLE DISORDER 23 0.0028
640 IMMUNOSUPPRESSION 25 0.0028
641 INFLUENZA 316 0.0028
642 PLEURAL EFFUSION 172 0.0028
643 EOSINOPHILIA 49 0.0028
644 SINUS BRADYCARDIA 27 0.0028
645 INFECTION 404 0.0028
646 WHITE BLOOD CELL COUNT INCREASED 107 0.0028
647 PROTEINURIA 53 0.0028
648 BLOOD MAGNESIUM DECREASED 24 0.0028
649 BLOOD POTASSIUM INCREASED 45 0.0028
650 MEDICATION ERROR 154 0.0028
651 TRANSIENT ISCHAEMIC ATTACK 93 0.0028
652 POLYNEUROPATHY 33 0.0028
653 CHEST DISCOMFORT 282 0.0028
654 COELIAC DISEASE 27 0.0027
655 RENAL TUBULAR NECROSIS 27 0.0027
656 PAIN OF SKIN 74 0.0027
657 HEPATOTOXICITY 61 0.0027
658 NECK PAIN 153 0.0027
659 NEUTROPHIL COUNT INCREASED 28 0.0027
660 RHABDOMYOLYSIS 114 0.0027
661 DIABETES MELLITUS 208 0.0027
662 BURNING SENSATION 191 0.0027
663 LUNG INFILTRATION 24 0.0027
664 PULMONARY FIBROSIS 52 0.0027
665 RESPIRATORY TRACT CONGESTION 43 0.0027
666 DIABETIC KETOACIDOSIS 65 0.0027
667 DERMATITIS ALLERGIC 34 0.0027
668 CYSTITIS 86 0.0027
669 DEEP VEIN THROMBOSIS 174 0.0027
670 UPPER-AIRWAY COUGH SYNDROME 22 0.0027
671 INTERNATIONAL NORMALISED RATIO INCREASED 76 0.0027
672 DIABETES MELLITUS INADEQUATE CONTROL 47 0.0027
673 HEART RATE INCREASED 263 0.0027
674 KIDNEY INFECTION 52 0.0026
675 ADVERSE REACTION 35 0.0026
676 FLUID RETENTION 134 0.0026
677 DYSPHONIA 154 0.0026
678 NAIL DISORDER 23 0.0026
679 GASTROINTESTINAL HAEMORRHAGE 219 0.0026
680 GROIN PAIN 23 0.0026
681 LOWER RESPIRATORY TRACT INFECTION 119 0.0026
682 NEPHROLITHIASIS 120 0.0026
683 DYSPHAGIA 248 0.0026
684 SHOCK HAEMORRHAGIC 21 0.0026
685 ILEUS 32 0.0026
686 RESPIRATORY DISTRESS 71 0.0026
687 PSEUDOMONAS INFECTION 22 0.0026
688 SKIN HAEMORRHAGE 38 0.0026
689 INJECTION SITE DISCOLOURATION 32 0.0026
690 CORONARY ARTERY OCCLUSION 35 0.0025
691 IMMUNODEFICIENCY 38 0.0025
692 HAIR DISORDER 21 0.0025
693 MYOCARDIAL ISCHAEMIA 29 0.0025
694 CLOSTRIDIUM DIFFICILE COLITIS 27 0.0025
695 ACUTE KIDNEY INJURY 389 0.0025
696 GASTRIC DISORDER 87 0.0025
697 BALANCE DISORDER 219 0.0025
698 PLATELET COUNT INCREASED 33 0.0025
699 ABNORMAL BEHAVIOUR 100 0.0025
700 GASTROINTESTINAL DISORDER 226 0.0025
701 INJECTION SITE IRRITATION 32 0.0025
702 WEIGHT INCREASED 562 0.0025
703 COORDINATION ABNORMAL 35 0.0025
704 UVEITIS 34 0.0025
705 INTERSTITIAL LUNG DISEASE 121 0.0025
706 HYPERKALAEMIA 87 0.0025
707 CONJUNCTIVITIS 46 0.0025
708 HAEMORRHAGE INTRACRANIAL 37 0.0025
709 DIALYSIS 35 0.0025
710 HEAD INJURY 78 0.0025
711 SCAR 42 0.0025
712 DRUG INEFFECTIVE 3224 0.0024
713 SUICIDE ATTEMPT 148 0.0024
714 EUPHORIC MOOD 25 0.0024
715 RED BLOOD CELL SEDIMENTATION RATE INCREASED 27 0.0024
716 EYE DISORDER 80 0.0024
717 RESPIRATORY FAILURE 176 0.0024
718 TOOTH LOSS 50 0.0024
719 PSYCHOMOTOR HYPERACTIVITY 40 0.0024
720 EMBOLISM 20 0.0024
721 ANGINA PECTORIS 69 0.0024
722 ACCIDENTAL OVERDOSE 88 0.0024
723 FUNGAL INFECTION 80 0.0024
724 TENDERNESS 25 0.0024
725 BLOOD GLUCOSE DECREASED 115 0.0024
726 PAIN IN EXTREMITY 705 0.0024
727 FOLLICULITIS 25 0.0024
728 UPPER RESPIRATORY TRACT INFECTION 110 0.0024
729 IMPAIRED DRIVING ABILITY 27 0.0024
730 ROAD TRAFFIC ACCIDENT 99 0.0024
731 ARRHYTHMIA 112 0.0024
732 HYPOTENSION 469 0.0023
733 INJECTION SITE PRURITUS 156 0.0023
734 SINUS TACHYCARDIA 33 0.0023
735 EYE PRURITUS 78 0.0023
736 HALLUCINATION, VISUAL 49 0.0023
737 RHINORRHOEA 150 0.0023
738 OPTIC NEURITIS 21 0.0023
739 FEELING JITTERY 44 0.0023
740 BLOOD CREATINE PHOSPHOKINASE INCREASED 66 0.0023
741 CEREBRAL HAEMORRHAGE 82 0.0023
742 CIRCULATORY COLLAPSE 39 0.0023
743 SCIATICA 36 0.0023
744 PARAESTHESIA 354 0.0022
745 NASAL CONGESTION 132 0.0022
746 COGNITIVE DISORDER 104 0.0022
747 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 116 0.0022
748 HYPOCALCAEMIA 42 0.0022
749 ADVERSE EVENT 204 0.0022
750 LEUKOCYTOSIS 40 0.0022
751 ACUTE MYOCARDIAL INFARCTION 65 0.0022
752 ULCER 35 0.0022
753 FLUID OVERLOAD 32 0.0022
754 INCREASED APPETITE 42 0.0022
755 GALLBLADDER DISORDER 39 0.0022
756 NEOPLASM 25 0.0022
757 SUBDURAL HAEMATOMA 31 0.0022
758 PULMONARY MASS 32 0.0021
759 NERVOUS SYSTEM DISORDER 67 0.0021
760 FALL 711 0.0021
761 DECREASED ACTIVITY 23 0.0021
762 THERAPEUTIC RESPONSE DECREASED 129 0.0021
763 SINUSITIS 218 0.0021
764 HAEMORRHAGE 222 0.0021
765 HAEMATOMA 55 0.0021
766 ABORTION SPONTANEOUS 85 0.0021
767 SINUS DISORDER 42 0.0021
768 CARDIOMEGALY 26 0.0021
769 COLITIS 80 0.0021
770 OCULAR HYPERAEMIA 100 0.0021
771 WEIGHT FLUCTUATION 22 0.0021
772 ERYTHEMA 430 0.0021
773 HYPOMAGNESAEMIA 29 0.0021
774 SPEECH DISORDER 109 0.0021
775 ACUTE RESPIRATORY FAILURE 40 0.0021
776 PERITONITIS 43 0.0021
777 VAGINAL HAEMORRHAGE 90 0.0021
778 ERECTILE DYSFUNCTION 53 0.0021
779 METABOLIC ACIDOSIS 66 0.0021
780 BREAST PAIN 22 0.0021
781 BLOOD PRESSURE DECREASED 137 0.0021
782 NASOPHARYNGITIS 379 0.0021
783 BLINDNESS UNILATERAL 29 0.0021
784 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 21 0.0020
785 DRUG INTOLERANCE 196 0.0020
786 EPILEPSY 62 0.0020
787 EYE DISCHARGE 21 0.0020
788 FIBROMYALGIA 49 0.0020
789 CYST 25 0.0020
790 GENERAL PHYSICAL HEALTH DETERIORATION 233 0.0020
791 GASTRIC HAEMORRHAGE 23 0.0020
792 MUSCULOSKELETAL DISORDER 38 0.0020
793 LIVER INJURY 49 0.0020
794 SKIN IRRITATION 91 0.0020
795 PNEUMONITIS 54 0.0020
796 TOOTH DISORDER 44 0.0020
797 SCHIZOPHRENIA 24 0.0020
798 UNEVALUABLE EVENT 149 0.0020
799 IRRITABLE BOWEL SYNDROME 42 0.0020
800 URINARY INCONTINENCE 58 0.0020
801 LIP SWELLING 65 0.0019
802 HYPERTENSION 413 0.0019
803 CARDIAC FAILURE 156 0.0019
804 NIGHTMARE 67 0.0019
805 MUSCULAR WEAKNESS 220 0.0019
806 APHONIA 27 0.0019
807 INJECTION SITE HAEMATOMA 28 0.0019
808 MICTURITION URGENCY 22 0.0019
809 HYPOAESTHESIA ORAL 29 0.0019
810 LYMPHOCYTE COUNT DECREASED 34 0.0019
811 PULMONARY HYPERTENSION 40 0.0019
812 SHOCK 44 0.0019
813 EYE IRRITATION 110 0.0019
814 MUSCLE TWITCHING 44 0.0019
815 LOCALISED INFECTION 46 0.0019
816 BLOOD GLUCOSE ABNORMAL 35 0.0019
817 THROAT IRRITATION 85 0.0019
818 NEUROPATHY PERIPHERAL 180 0.0019
819 PULMONARY OEDEMA 84 0.0019
820 URTICARIA 313 0.0019
821 DELUSION 29 0.0019
822 HUNGER 26 0.0019
823 HERPES ZOSTER 107 0.0019
824 EYE INFECTION 21 0.0019
825 ATAXIA 22 0.0019
826 NODULE 24 0.0018
827 ORTHOSTATIC HYPOTENSION 32 0.0018
828 SKIN BURNING SENSATION 131 0.0018
829 BLOOD GLUCOSE INCREASED 344 0.0018
830 FEAR 49 0.0018
831 BRADYCARDIA 96 0.0018
832 MUSCULOSKELETAL DISCOMFORT 31 0.0018
833 PAIN IN JAW 51 0.0018
834 LUNG DISORDER 88 0.0018
835 SMALL INTESTINAL OBSTRUCTION 22 0.0018
836 HIATUS HERNIA 23 0.0018
837 IMPAIRED HEALING 58 0.0018
838 SWELLING 165 0.0018
839 END STAGE RENAL DISEASE 32 0.0018
840 HYPOGLYCAEMIA 85 0.0018
841 THROMBOSIS 139 0.0017
842 NEURALGIA 42 0.0017
843 APHASIA 52 0.0017
844 HERNIA 33 0.0017
845 HYPERCALCAEMIA 21 0.0017
846 SECRETION DISCHARGE 21 0.0017
847 FEEDING DISORDER 34 0.0017
848 OSTEOMYELITIS 30 0.0017
849 RIB FRACTURE 34 0.0017
850 DRUG EFFECT INCOMPLETE 60 0.0017
851 BURSITIS 20 0.0016
852 HYPOXIA 58 0.0016
853 GAIT DISTURBANCE 314 0.0016
854 HEART RATE IRREGULAR 37 0.0016
855 INJECTION SITE MASS 60 0.0016
856 LACRIMATION INCREASED 49 0.0016
857 CARDIOVASCULAR DISORDER 41 0.0016
858 BRAIN OEDEMA 20 0.0016
859 HOT FLUSH 119 0.0016
860 DYSSTASIA 46 0.0016
861 ATRIAL FIBRILLATION 153 0.0016
862 SNEEZING 35 0.0016
863 INTERVERTEBRAL DISC PROTRUSION 34 0.0016
864 MIDDLE INSOMNIA 29 0.0016
865 TYPE 2 DIABETES MELLITUS 52 0.0015
866 PARALYSIS 22 0.0015
867 FOOT FRACTURE 29 0.0015
868 PULMONARY EMBOLISM 145 0.0015
869 CARDIAC ARREST 125 0.0015
870 PNEUMOTHORAX 24 0.0015
871 UNRESPONSIVE TO STIMULI 39 0.0015
872 POST PROCEDURAL COMPLICATION 29 0.0015
873 GLAUCOMA 29 0.0015
874 INJECTION SITE HAEMORRHAGE 119 0.0015
875 DRUG TOXICITY 20 0.0015
876 ISCHAEMIC STROKE 26 0.0015
877 ECONOMIC PROBLEM 22 0.0015
878 WHEEZING 86 0.0014
879 JOINT SWELLING 175 0.0014
880 DIVERTICULITIS 40 0.0014
881 HEMIPARESIS 24 0.0014
882 JOINT STIFFNESS 37 0.0014
883 PSORIASIS 184 0.0014
884 OFF LABEL USE 1226 0.0014
885 TOXIC EPIDERMAL NECROLYSIS 21 0.0014
886 INTESTINAL OBSTRUCTION 52 0.0014
887 NO ADVERSE EVENT 247 0.0014
888 CONDITION AGGRAVATED 414 0.0014
889 PNEUMONIA ASPIRATION 34 0.0014
890 ADVERSE DRUG REACTION 122 0.0014
891 BACK DISORDER 22 0.0014
892 ASTHMA 152 0.0013
893 COLON CANCER 20 0.0013
894 THROAT TIGHTNESS 36 0.0013
895 CATARACT 79 0.0013
896 URINARY RETENTION 44 0.0013
897 BONE DISORDER 24 0.0013
898 EXTRA DOSE ADMINISTERED 53 0.0013
899 DYSKINESIA 53 0.0013
900 MYOCARDIAL INFARCTION 227 0.0013
901 ILL-DEFINED DISORDER 79 0.0013
902 MUCOSAL INFLAMMATION 34 0.0013
903 MOVEMENT DISORDER 41 0.0013
904 CYANOSIS 20 0.0013
905 ARTHRITIS 100 0.0013
906 CEREBRAL INFARCTION 31 0.0013
907 ANHEDONIA 33 0.0013
908 HYPERSENSITIVITY 230 0.0012
909 CORONARY ARTERY DISEASE 37 0.0012
910 LIMB INJURY 33 0.0012
911 FEBRILE NEUTROPENIA 80 0.0012
912 SYRINGE ISSUE 21 0.0012
913 CLOSTRIDIUM DIFFICILE INFECTION 26 0.0012
914 MUSCULOSKELETAL STIFFNESS 104 0.0012
915 PERIPHERAL SWELLING 182 0.0012
916 INJURY ASSOCIATED WITH DEVICE 24 0.0012
917 DISCOMFORT 71 0.0012
918 OVERDOSE 251 0.0012
919 DEPRESSED LEVEL OF CONSCIOUSNESS 46 0.0012
920 THERAPEUTIC RESPONSE UNEXPECTED 52 0.0012
921 CEREBROVASCULAR ACCIDENT 194 0.0011
922 PRODUCT QUALITY ISSUE 154 0.0011
923 LIVER FUNCTION TEST INCREASED 24 0.0011
924 CARDIAC DISORDER 104 0.0011
925 HEART RATE DECREASED 39 0.0011
926 EXPOSURE DURING PREGNANCY 68 0.0011
927 CHRONIC KIDNEY DISEASE 82 0.0011
928 RENAL INJURY 32 0.0011
929 ANGIOEDEMA 47 0.0011
930 JOINT INJURY 22 0.0010
931 DRUG EXPOSURE DURING PREGNANCY 35 0.0010
932 ELECTROCARDIOGRAM QT PROLONGED 37 0.0010
933 UNDERDOSE 75 0.0010
934 CARDIAC FAILURE CONGESTIVE 80 0.0010
935 INCORRECT DOSE ADMINISTERED 226 0.0010
936 RESPIRATORY ARREST 27 0.0010
937 WRONG TECHNIQUE IN DRUG USAGE PROCESS 35 0.0010
938 INTENTIONAL DOSE OMISSION 27 0.0009
939 OSTEOARTHRITIS 40 0.0009
940 COLITIS ULCERATIVE 42 0.0009
941 INTENTIONAL PRODUCT USE ISSUE 79 0.0009
942 SYSTEMIC LUPUS ERYTHEMATOSUS 32 0.0009
943 WOUND 25 0.0009
944 INFLAMMATION 46 0.0009
945 PREMATURE BABY 26 0.0009
946 INJECTION SITE SWELLING 66 0.0009
947 DEMENTIA 24 0.0009
948 MOBILITY DECREASED 61 0.0008
949 WITHDRAWAL SYNDROME 35 0.0008
950 NEEDLE ISSUE 24 0.0008
951 SEIZURE 93 0.0008
952 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 44 0.0008
953 LUNG NEOPLASM MALIGNANT 32 0.0008
954 OXYGEN SATURATION DECREASED 43 0.0008
955 ARTHROPATHY 42 0.0008
956 MATERNAL EXPOSURE DURING PREGNANCY 67 0.0008
957 FEMUR FRACTURE 23 0.0007
958 C-REACTIVE PROTEIN INCREASED 27 0.0007
959 DEATH 637 0.0007
960 ACNE 56 0.0007
961 PRODUCT USE ISSUE 138 0.0007
962 DRUG ABUSE 61 0.0007
963 DRUG EFFECT DECREASED 39 0.0007
964 THERAPY CESSATION 37 0.0007
965 DISEASE PROGRESSION 83 0.0007
966 FOETAL EXPOSURE DURING PREGNANCY 57 0.0007
967 FLUSHING 71 0.0007
968 LIMB DISCOMFORT 21 0.0007
969 NEOPLASM MALIGNANT 44 0.0007
970 OSTEOPOROSIS 26 0.0006
971 SURGERY 36 0.0006
972 HYPOACUSIS 26 0.0006
973 EMOTIONAL DISTRESS 73 0.0006
974 BLOOD CHOLESTEROL INCREASED 28 0.0006
975 COMPLETED SUICIDE 50 0.0006
976 INJURY 42 0.0006
977 INJECTION SITE PAIN 180 0.0006
978 TOXICITY TO VARIOUS AGENTS 96 0.0006
979 ANAPHYLACTIC REACTION 31 0.0006
980 RHEUMATOID ARTHRITIS 56 0.0005
981 ACCIDENTAL EXPOSURE TO PRODUCT 49 0.0005
982 DRUG WITHDRAWAL SYNDROME 41 0.0005
983 HOSPITALISATION 70 0.0005
984 DRUG DEPENDENCE 71 0.0004
985 PRODUCT USE IN UNAPPROVED INDICATION 105 0.0004
986 INTENTIONAL OVERDOSE 27 0.0004
987 PRODUCT DOSE OMISSION 26 0.0004
988 BREAST CANCER 32 0.0003
989 DEVICE MALFUNCTION 22 0.0003
990 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 57 0.0003
991 PROSTATE CANCER 21 0.0003
992 COVID-19 21 0.0001